Nature Biotechnology · 2003 · 49 citations · 16 references
Cell TherapyGraft-versus-host Disease ModelTransplantationAutoimmune DiseaseMedicineT-regulatory CellImmunologyPathologyAutoimmunityGraft SurvivalCell TransplantationImmunotherapyT-cell FactorCell BiologyGraft RejectionHigh-throughput Screening Increases
16
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Yvette Latchman, Clive R. Wood, Tatyana Chernova et al. · Nature Immunology · 2001 · 2.9K citations
Cancer Immunosurveillance, Signal Transduction, Immunology +8